Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues	$ 1,005,754	$ 728,723	$ 590,961
Operating expenses:
Cost of revenues (excluding depreciation and amortization)	399,552	274,482	215,466
General and administrative expenses	204,595	205,419	213,615
Selling and marketing expenses	314,514	288,441	299,238
Research and development expenses	90,679	73,869	69,454
Depreciation and amortization	56,100	51,149	51,878
Acquisition-related expenses	8,229	203	344
Restructuring expenses	0	2,845
Total operating expenses	1,073,669	896,408	849,995
Loss from operations	(67,915)	(167,685)	(259,034)
Interest expense, net	7,147	10,939	7,303
Other (income) / expenses	(115)	7,820	13,983
Change in fair value of warrant and derivative liabilities			410
Total other expenses	7,032	18,759	21,696
Loss before income taxes	(74,947)	(186,444)	(280,730)
Income tax (benefit) / provision	(5,176)	1,037	(1,491)
Net loss	(69,771)	(187,481)	(279,239)
Other comprehensive loss / (income):
Foreign currency translation adjustment	3	(35)	(56)
Total comprehensive loss	(69,774)	(187,446)	(279,183)
Net loss per share
Net Income (Loss)	(69,771)	(187,481)	(279,239)
Net loss available to common stockholders	$ (69,771)	$ (187,481)	$ (279,239)
Basic loss per share	$ (0.38)	$ (1.2)	$ (2.01)
Diluted loss per share	$ (0.38)	$ (1.2)	$ (2.01)
Weighted average number of shares used to compute net loss per share
Basic	185,984,107	156,697,308	138,985,265
Diluted	185,984,107	156,697,308	138,985,265